AIM 2: To determine whether there is a role for assessing peripheral blood mononuclear cell (PBMC) and urine cell gene expression patterns as a means of measuring the immunologic and clinical status of kidney transplant recipients, we will compare gene expression profiles among PBMC, urine and biopsy samples.